291 related articles for article (PubMed ID: 8473016)
1. Platelet-activating factor-induced human eosinophil activation. Generation and release of cyclo-oxygenase metabolites in human blood eosinophils from asthmatics.
Kroegel C; Matthys H
Immunology; 1993 Feb; 78(2):279-85. PubMed ID: 8473016
[TBL] [Abstract][Full Text] [Related]
2. Platelet activating factor stimulates cyclo-oxygenase activity in guinea pig eosinophils. Concerted biosynthesis of thromboxane A2 and E-series prostaglandins.
Giembycz MA; Kroegel C; Barnes PJ
J Immunol; 1990 May; 144(9):3489-97. PubMed ID: 2158510
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of degranulation from human eosinophils by platelet-activating factor.
Kroegel C; Yukawa T; Dent G; Venge P; Chung KF; Barnes PJ
J Immunol; 1989 May; 142(10):3518-26. PubMed ID: 2541198
[TBL] [Abstract][Full Text] [Related]
4. Platelet-activating factor stimulates arachidonic acid release and enhances thromboxane B2 production in intact fetal rat brain ex vivo.
Kunievsky B; Yavin E
J Pharmacol Exp Ther; 1992 Nov; 263(2):562-8. PubMed ID: 1432689
[TBL] [Abstract][Full Text] [Related]
5. Effect of interleukin-1 beta, tumour necrosis factor-alpha and interferon-gamma on the induction of cyclo-oxygenase-2 in cultured human airway smooth muscle cells.
Pang L; Knox AJ
Br J Pharmacol; 1997 Jun; 121(3):579-87. PubMed ID: 9179403
[TBL] [Abstract][Full Text] [Related]
6. The inhibitory effects of mercaptoalkylguanidines on cyclo-oxygenase activity.
Zingarelli B; Southan GJ; Gilad E; O'Connor M; Salzman AL; Szabó C
Br J Pharmacol; 1997 Feb; 120(3):357-66. PubMed ID: 9031736
[TBL] [Abstract][Full Text] [Related]
7. Leukotriene C4 production from human eosinophils in vitro. Role of eosinophil chemotactic factors on eosinophil activation.
Tamura N; Agrawal DK; Townley RG
J Immunol; 1988 Dec; 141(12):4291-7. PubMed ID: 2848892
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase C inhibition enhances platelet-activating factor-induced eicosanoid production in human eosinophils.
Dent G; Muñoz NM; Rühlmann E; Zhu X; Leff AR; Magnussen H; Rabe KF
Am J Respir Cell Mol Biol; 1998 Jan; 18(1):136-44. PubMed ID: 9448055
[TBL] [Abstract][Full Text] [Related]
9. Selective inhibition of arachidonic acid metabolite release from human lung tissue by antiinflammatory steroids.
Schleimer RP; Davidson DA; Lichtenstein LM; Adkinson NF
J Immunol; 1986 Apr; 136(8):3006-11. PubMed ID: 3082976
[TBL] [Abstract][Full Text] [Related]
10. Anaphylactic- and calcium-dependent generation of prostaglandin D2 (PGD2), thromboxane B2, and other cyclooxygenase products of arachidonic acid by dispersed human lung cells and relationship to histamine release.
Holgate ST; Burns GB; Robinson C; Church MK
J Immunol; 1984 Oct; 133(4):2138-44. PubMed ID: 6206153
[TBL] [Abstract][Full Text] [Related]
11. Platelet-activating factor induces eosinophil peroxidase release from purified human eosinophils.
Kroegel C; Yukawa T; Dent G; Chanez P; Chung KF; Barnes PJ
Immunology; 1988 Jul; 64(3):559-61. PubMed ID: 3410498
[TBL] [Abstract][Full Text] [Related]
12. Enhanced glomerular thromboxane A2 mediates some pathophysiologic effect of platelet-activating factor in rabbit nephrotoxic nephritis: evidence from biochemical measurements and inhibitor trials.
Macconi D; Benigni A; Morigi M; Ubiali A; Orisio S; Livio M; Perico N; Bertani T; Remuzzi G; Patrono C
J Lab Clin Med; 1989 May; 113(5):549-60. PubMed ID: 2541212
[TBL] [Abstract][Full Text] [Related]
13. Density heterogeneity of eosinophil leucocytes: induction of hypodense eosinophils by platelet-activating factor.
Yukawa T; Kroegel C; Evans P; Fukuda T; Chung KF; Barnes PJ
Immunology; 1989 Sep; 68(1):140-3. PubMed ID: 2807369
[TBL] [Abstract][Full Text] [Related]
14. Interactions between platelet-activating factor and prostanoids during mesenteric ischemia-reperfusion-induced shock in the anesthetized dog.
Filep JG; Braquet P; Mózes T
Circ Shock; 1991 Sep; 35(1):1-8. PubMed ID: 1742856
[TBL] [Abstract][Full Text] [Related]
15. Platelet-activating factor is a potent stimulus for renal prostaglandin synthesis: possible significance in unilateral ureteral obstruction.
Weisman SM; Felsen D; Vaughan ED
J Pharmacol Exp Ther; 1985 Oct; 235(1):10-5. PubMed ID: 3862805
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of leukotriene C4 and B4 release by human eosinophils with the new 5-lipoxygenase inhibitor 6-hydroxy-2(4-sulfamoylbenzylamino)-4,5,7-trimethylbenzothiazo le hydrochloride.
Fukuda T; Numao T; Akutsu I; Toda M; Motojima S; Makino S
Arzneimittelforschung; 1995 Sep; 45(9):1002-4. PubMed ID: 7488299
[TBL] [Abstract][Full Text] [Related]
17. Triple role of platelet-activating factor in eosinophil migration across monolayers of lung epithelial cells: eosinophil chemoattractant and priming agent and epithelial cell activator.
Liu L; Zuurbier AE; Mul FP; Verhoeven AJ; Lutter R; Knol EF; Roos D
J Immunol; 1998 Sep; 161(6):3064-70. PubMed ID: 9743372
[TBL] [Abstract][Full Text] [Related]
18. [Effects of platelet activating factor on release of thromboxane B2 from human granulocytes and platelets].
Imai T; Horikoshi S; Kurokawa M; Idaira K; Mita S; Adachi M; Okamoto M
Arerugi; 1994 Jul; 43(7):809-14. PubMed ID: 7980021
[TBL] [Abstract][Full Text] [Related]
19. Evidence for prostanoid biosynthesis as a biochemical feature of certain subclasses of non-small cell carcinomas of the lung as determined in established cell lines derived from human lung tumors.
Hubbard WC; Alley MC; Gray GN; Green KC; McLemore TL; Boyd MR
Cancer Res; 1989 Feb; 49(4):826-32. PubMed ID: 2536293
[TBL] [Abstract][Full Text] [Related]
20. IgG-dependent generation of platelet-activating factor by normal and low density human eosinophils.
Cromwell O; Wardlaw AJ; Champion A; Moqbel R; Osei D; Kay AB
J Immunol; 1990 Dec; 145(11):3862-8. PubMed ID: 2246516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
